Precision Biosensor, Inc. (KOSDAQ:335810)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,140.00
-140.00 (-6.14%)
At close: Mar 9, 2026
-21.18%
Market Cap 46.97B
Revenue (ttm) 19.74B
Net Income (ttm) -7.88B
Shares Out 21.95M
EPS (ttm) -678.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 27,343
Average Volume 23,940
Open 2,300.00
Previous Close 2,280.00
Day's Range 2,100.00 - 2,300.00
52-Week Range 2,100.00 - 4,500.00
Beta 0.61
RSI 23.65
Earnings Date Mar 18, 2026

About Precision Biosensor

Precision Biosensor, Inc. engages in the development, production, and sale of immune diagnostic kits in South Korea. It offers Exdia TRF Plus, an immunodiagnosis POCT platform; and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform. The company was founded in 2009 and is headquartered in Daejeon, South Korea. [Read more]

Industry Measuring and Controlling Devices, not elsewhere classified
Founded 2009
Employees 98
Stock Exchange KOSDAQ
Ticker Symbol 335810
Full Company Profile

Financial Performance

In 2024, Precision Biosensor's revenue was 19.13 billion, a decrease of -6.16% compared to the previous year's 20.39 billion. Losses were -7.31 billion, 62.7% more than in 2023.

Financial Statements

News

There is no news available yet.